CARLSBAD, CA—April 27th, 2022—DCN Dx, a global leader in the end-to-end development, manufacture, and commercialization of point-of-use tests, has completed a West Coast acquisition of Biomed Diagnostics, Inc., a microbiological testing products company based in White City, OR.
Read More